focus -WSS

focus

author：leisure time 2025-08-12 05:30:40 - browse：64

Peter Marks. -- health coverage from STAT — Peter Marks, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration. Susan Walsh-Pool/Getty Images

Peter Marks wants drug developers to ask more stupid questions.

It’s part of the top Food and Drug Administration official’s plan to reinvigorate gene therapy, a field that has struggled despite significant technological advances. Some companies are shelving programs or going out of business, even when they have promising data.

The problems are numerous: The diseases are often exceptionally rare, limiting the potential market. Manufacturing at commercial quality is complex and expensive. Proving a drug works can be difficult, because there may be too few patients to run a traditional randomized study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Gene therapy denied for Afghan refugee whose father aided U.S.

WSS

Orangutan used medicinal plant to treat wound, first time ever seen

Why does health care cost so much? A reading guide

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Getting Alzheimer's drug Leqembi to patients can be a challenge

Cancer researcher Catriona Jamieson is sending tumors into space

Medicare Advantage overpayments discussion gets experts fired up

explore

focus

focus

Peter Hotez and the public health issue of online harassment

Gene therapy denied for Afghan refugee whose father aided U.S.

Tori Bowie and the unacceptable rates of Black maternal death

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Novavax promises a turnaround & Lilly roils the obesity market

Medicare Advantage coverage denials need scrutiny, senators say

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Profiling embryos to choose those with higher IQs is almost a reality

Hepatitis C has a cure — but many Americans still lack access to it

Q&A: Jennifer Adair on making gene therapy available globally

focus

Does Paxlovid work in people vaccinated against Covid

MultiPlan and major insurers sued for alleged medical price

A preacher's new calling: Diversifying neuroscience research

Bird flu in milk supply is likely coming from asymptomatic cows

A preacher's new calling: Diversifying neuroscience research

Fauci's latest grilling in Congress: 9 hours, behind closed doors

hotspot

focus

leisure time

hotspot